Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: Organigram | Rare Historical Photos

Organigram Global Q2 Earnings Call Highlights

Organigram Global (NASDAQ:OGI) reported a weaker second quarter for fiscal 2026, with management attributing the decline to operational issues in key product categories, softer Canadian cannabis market growth and continued challenges with international flower specifications. Chief Executive Officer

MarketBeat

OrganiGram (OGI) Joins Cannabis Stock Rally After Trump Signals Policy Shift

Organigram Global Inc (NASDAQ: OGI) shares are trading sharply higher Monday afternoon, joining a rally across the cannabis sector.

Benzinga

Organigram Posts Wider Loss, Eyes Profitability In Near Term

Cannabis grower Organigram Holdings Inc. (NASDAQ:OGI) reported third-quarter 2025 net sales of $51.14 million, approximately $70.8 million Canadian dollars (CAD), up 72% year-over-year, beating the consensus of $48.33 million.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition Deal

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has announced the acquisition of 100% of Motif Labs Ltd. for CA$90 million ($64 million), comprising of CA$50 million in cash and CA$40 million in Organigram common shares, based on a 30-day trading VWAP of $2.321 on the TSX. An additional CA$10 million…

Benzinga

3 Buy-Rated Cannabis Stocks Under $10 to Scoop Up Now

These three buy-rated cannabis stocks could be set to benefit as both leading presidential candidates show growing support for legalization.

Barchart

5 Microcap Stocks With 65% or More Upside Potential

While they do carry higher-than-average risk, these microcaps also offer major upside potential for investors seeking startup-sized returns.

Barchart

3 Tobacco Stocks to Watch With Weekly Profits Ahead

Despite encountering various challenges, the tobacco industry is set to grow due to sustained consumption and the introduction of innovative products. Therefore, it could be wise to add fundamentally strong tobacco stocks Japan Tobacco Inc. (JAPAY), Altria Group, Inc. (MO), and British American Tobacco p.l.c. (BTI) to one’s watchlist. Read…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Tobacco Stocks Gaining Traction in 2024

Despite encountering various challenges, the tobacco industry thrives on sustained consumption and the introduction of innovative products. Therefore, investors could consider buying fundamentally strong tobacco stocks Vector Group (VGR), Universal (UVV), and British American Tobacco (BTI). Read on….

StockNews.com

3 Tobacco Stock Picks for December Portfolio Prosperity

Despite various challenges, the tobacco industry thrives on sustained consumption. Moreover, introducing new products is expected to boost the industry’s long-term prospects. Therefore, investors could look to invest in the fundamentally strong tobacco stocks Vector Group (VGR), British American Tobacco (BTI), and Turning Point Brands (TPB). Read on….

StockNews.com

3 Cannabis Stocks to Consider Buying as HHS Recommends Easing Restrictions on Marijuana

Cannabis stocks could deliver outsized gains if marijuana is rescheduled, per a recent HHS recommendation. While the DEA weighs its options, here's a look at three names with significant upside potential, according to analysts.

Barchart

Want Exposure To The Canadian Recreational Cannabis Market? These Are The 3 Best Picks, According To A Cantor Analyst

In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald offered an update on the performance of Canada’s cannabis Licensed Producers in the August quarter, based on data obtained by the market scanner Hifyre.

Benzinga

This Analyst Expects Stabilization Across Canadian Cannabis Market, Revises Sales Estimates For Cannabis LPs

The Canadian cannabis industry has become a competitive field over the past few years, which doesn’t come as a surprise considering its exponential growth over the same period.

Benzinga

OrganiGram Beat Fact Set Expectations: "The Stock Represents Good Value," Analyst Says

On Thursday, Organigram Holdings Inc. (OGI.TO) (NASDAQ: OGI), a cannabis company focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada,

Benzinga

2Q Canada Recreational Cannabis Market Analysis: +21 YoY Growth Outperforming The U.S.

In a recent analyst note, Cantor Fitzgerald's Pablo Zuanic gave an overview of the Canadian recreational cannabis market in the second quarter of 2022, according to data collected by Hifyre, a leading in-shop and online digital toolset for cannabis dispensaries.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Organigram Revenue Grows 88% YoY, Provides Outlook

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) released results for the third quarter ended May 31, 2022, revealing net revenue increased 88% to $38.1 million, from $20.3 million in Q3 Fiscal 2021.

Benzinga

Organigram Reaches Proposed Settlement In 2016 Class Action

Organigram Holdings Inc.

Benzinga

Organigram Q2 Fiscal 2022 Revenue Grows 117% YoY Primaraly Because Of This

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI), the parent company of Organigram Inc., released its results for the second quarter ended February 28, 2022.

Benzinga

Here's Why OrganiGram Shares Are Rising

OrganiGram Holdings Inc (NASDAQ: OGI) shares are trading higher by 8.72% at $1.62 during Tuesday's pre-market session after the company reported better-than-expected second-quarter sales results and said it expects third-quarter sales to be higher than second-quarter 2022.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Organigram Shares Are Trading Higher Today? Posts Record High Net Revenue In Q2, Still Among Top Canadian LPs

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of the cannabis company Organigram Inc, announced its results for the second quarter ended February 28, 2022.

Benzinga

These 7 Cannabis Stocks May Be Underappreciated As Market Continues To Rebound

Over the past couple of months, the cannabis sector has faced many challenges resulting in marijuana stocks dropping.

Benzinga

Here's Why OrganiGram Shares Are Rising

Shares of many cannabis stocks, including OrganiGram Holdings Inc (NASDAQ: OGI), are trading higher following an afternoon report Thursday U.S. House Rules Committee has scheduled a Monday-afternoon meeting to prep federal marijuana legalization bill for floor action.

Benzinga

Organigram Joins The Pledge 1% Movement To Help Local Volunteer Programs

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) launched its social impact strategy ‘Organigram Operating for Good’ with the purpose of ‘Building healthy communities where we live and work.’ As part of this strategy the company has committed to giving back by

Benzinga

Organigram Gets Additional CA$6.3M Investment From BAT, Which Raises Its Stake In The Company To 19.5%

BAT Exercises Top-Up Rights to Invest $6.3 Million Resulting in an Increase in Equity Position from 18.8% to 19.5%

Benzinga

Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified

Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has appointed Ana Bowman as a chief financial officer, effective February 22.

Benzinga

Benzinga Interview: Organigram CEO Beena Goldenberg Discusses Company Performance And Canadian Cannabis Market

OrganiGram Holdings Inc (NASDAQ: OGI) (TSE: OGI) CEO Beena Goldenberg recently spoke with Benzinga to discuss the company's ongoing growth and Q2 success.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.